Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 1475 entries
View as:

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00412984 Org: User:
Start: 12/31/06 End: 05/25/11 Due: 05/25/12

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05946941 Org: User:
Start: 09/11/23 End: 11/16/28 Due: 11/16/29

A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02061761 Org: User:
Start: 03/13/14 End: 02/16/22 Due: 02/16/23

A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05852769 Org: User:
Start: 05/31/23 End: 08/24/23 Due: 08/24/24

A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes

Phase: N/A Priority: Normal
NCT ID: NCT03714022 Org: User:
Start: 11/09/18 End: 04/02/19 Due: 04/02/20

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Phase: N/A Priority: Normal
NCT ID: NCT00696072 Org: User:
Start: 08/31/08 End: 06/30/14 Due: 06/30/15

Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin

Phase: N/A Priority: Normal
NCT ID: NCT03466814 Org: User:
Start: 04/06/18 End: 07/21/21 Due: 07/21/22

Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens

Phase: N/A Priority: Normal
NCT ID: NCT02211807 Org: User:
Start: 04/30/14 End: 08/31/14 Due: 08/31/15

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT06481306 Org: User:
Start: 07/17/24 End: 11/16/27 Due: 11/16/28

Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01245556 Org: User:
Start: 01/31/11 End: 11/30/12 Due: 11/30/13

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Phase: N/A Priority: Normal
NCT ID: NCT00349518 Org: User:
Start: 12/31/06 End: - Due: -

Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents

Phase: N/A Priority: Normal
NCT ID: NCT01137838 Org: User:
Start: 10/31/09 End: 10/31/10 Due: 10/31/11

An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT03414983 Org: User:
Start: 02/20/18 End: 12/28/22 Due: 12/28/23

Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT00371150 Org: User:
Start: 11/30/06 End: 03/31/11 Due: 03/31/12

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00744497 Org: User:
Start: 10/31/08 End: 07/31/15 Due: 07/31/16

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02156076 Org: User:
Start: 07/25/14 End: 06/01/16 Due: 06/01/17

A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04305899 Org: User:
Start: 08/31/20 End: 11/25/20 Due: 11/25/21

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03486899 Org: User:
Start: 06/19/18 End: 08/17/21 Due: 08/17/22

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04943900 Org: User:
Start: 08/09/21 End: 02/27/25 Due: 02/27/26

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00793897 Org: User:
Start: 04/30/09 End: 06/30/12 Due: 06/30/13

Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)

Phase: N/A Priority: Normal
NCT ID: NCT02038933 Org: User:
Start: 03/05/14 End: 10/08/20 Due: 10/08/21

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02792335 Org: User:
Start: 01/31/12 End: 08/31/14 Due: 08/31/15

A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04055506 Org: User:
Start: 08/14/19 End: 09/21/19 Due: 09/21/20

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Phase: N/A Priority: Normal
NCT ID: NCT02592798 Org: User:
Start: 03/09/16 End: 01/28/20 Due: 01/28/21

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04349267 Org: User:
Start: 07/14/20 End: 08/22/24 Due: 08/22/25